Web Results

en.wikipedia.org/wiki/Bruesewitz_v._Wyeth

Bruesewitz v. Wyeth, 562 U.S. 223 (2011), is a United States Supreme Court case that decided whether a section of the National Childhood Vaccine Injury Act of 1986 preempts all vaccine design defect claims against vaccine manufacturers . Contents. [hide]. 1 Background; 2 Decision; 3 See also; 4 References; 5 External ...

caselaw.findlaw.com/us-supreme-court/09-152.html

BRUESEWITZ ET AL. v. WYETH LLC, FKA WYETH, INC., ET AL., (2011). No. 09- 152. Argued: October 12, 2010 Decided: February 22, 2011. The National Childhood Vaccine Injury Act of 1986 (NCVIA or Act) created a no-fault compensation program to stabilize a vaccine market adversely affected by an increase in ...

caselaw.findlaw.com/us-supreme-court/555/555.html

Case opinion for US Supreme Court WYETH v. LEVINE. Read the Court's full decision on FindLaw.

healthland.time.com/2011/02/24/bruesewitz-v-wyeth-what-the-supreme-court-decision-means-for-vaccines

Feb 24, 2011 ... Vaccine injury is a tricky thing to prove — medically and legally. So it was inevitably controversial when the Supreme Court ruled on Tuesday against the parents of Hannah Bruesewitz, 18, who suffered seizures and permanent brain damage after receiving a diptheria-tetanus-pertussis (DTP) vaccine i...

www.courtlistener.com/opinion/1897541/perez-v-wyeth-laboratories-inc

Aug 9, 1999 ... Charles J. Walsh et al., The Learned Intermediary Doctrine: The Correct Prescription for Drug Labeling, 48 Rutgers L.Rev. 821, 869 (1994). Thus, under the new Restatement, "warnings may have to be provided to a health-care provider or even to the patient," depending on the circumstances. William A.

www.americanbar.org/content/dam/aba/administrative/administrative_law/kazhdan_final_version_website.authcheckdam.pdf

state law required a manufacturer to warn prospective buyers of potential. 28. See id. at 2573. 29. Mensing v. Wyeth, Inc., 588 F.3d 603, 605 n.1 (8th Cir. 2009), rev'd sub nom. PLIVA, 131 S. Ct. 2567. 30. PLIVA, 131 S. Ct. at 2573. 31. Jeffrey M. Karp et al., Metoclopramide Treatment of Tardive Dyskinesia, 246 J. AM. MED.

scholarship.law.berkeley.edu/cgi/viewcontent.cgi?article=1951&context=btlj

Jan 6, 2012 ... WYETH ANDPLIVA: THE LAW OF INADEQUATE DRUG LABELING. Daniel Kazhdan†. In Wyeth v. Levine, decided in 2009, the U.S. Supreme Court held that .... Jeffrey M. Karp et al., Metoclopramide Treatment of Tardive Dyskinesia, 246 J. AM. ..... New Mexico, 131 S. Ct. 2705 (2011) (8 amici); Freeman v.

files.consumerfinance.gov/f/201212_CFPB_Freeman-amicus-SCt-merits.pdf

10-1042. In the Supreme Court of the United States. TAMMY FORET FREEMAN, ET AL., PETITIONERS v. QUICKEN LOANS, INC. ON WRIT OF CERTIORARI ... Bruesewitz v. Wyeth LLC, 131 S. Ct. 1068 (2011) . . . . . . . 13. Chevron U.S.A. Inc. v. NRDC, 467 U.S. 837 (1984) . . 11, 24. Christensen v. Harris County, 529 U.S. ...

www.aei.org/publication/west-virginia-supreme-court-strikes-down-learned-intermediary-rule

Nov 15, 2007 ... Wyeth Laboratories, Inc. was not followed in other jurisdictions until 2007,[3] when the West Virginia Supreme Court used the rationalization of ..... Alabama law); Stilwell v. Smith & Nephew, Inc., 482 F.3d 1187, 1194 (9th Cir. 2007) ( applying Arizona law); In re Zyprexa Prods. Liab. Litig. v. Eli Lilly & Co., ___ ...